Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.

http://www.wikidata.org/entity/Q38021384

about

Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma Pancreatic cancer surgery: past, present, and future Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients.Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer.Intensity of follow-up after pancreatic cancer resection Pancreatic biomarkers: could they be the answer?Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma.Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial.CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer.Diagnostic value of combining CA 19-9 and K-ras gene mutation in pancreatic carcinoma: a meta-analysis.Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer.Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation.Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort.Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer HLA-G impairs host immune response and predicts poor prognosis in pancreatic cancer Multimodality treatment of recurrent pancreatic cancer: Mith or reality?Pancreatic Cancer: a Challenge to Cure Nuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer.Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.Complexity of molecular alterations impacts pancreatic cancer prognosis.Identification of Poor-outcome Biliopancreatic Carcinoma Patients With Two-marker Signature Based on ATF6α and p-p38 "STARD Compliant".Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study Gold Nanoparticles for In Vitro Diagnostics.The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science.Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.

P2860

Q26739910-34395D51-7FF6-4810-8677-66AE8420A163 Q26781555-90FFFF19-D26A-43E9-B64A-E9C5D3934C33 Q26782719-8CFBFFFA-282E-4653-8F30-EC121DB7130F Q28066454-557644DC-9560-44DF-AEF4-A3F26CED2DBF Q30368922-0E995505-1397-48E0-9859-5ECA29820715 Q33598160-75CB6612-67A0-4CCF-AEE4-5E79EA2F602D Q33624392-4E73FEE8-A7C4-4480-B705-8AF0E8E0E9F7 Q33655712-EE1251CC-C0CA-40E9-84AD-D3B499A9AE5A Q33762042-FC63EACD-FF37-43B6-A2A1-03B11ED5BFB2 Q33791048-148DFD89-78A5-4E2D-941A-E6F65A106D53 Q33801371-57912C8F-18DE-4E1B-B0DD-776EB1F58B45 Q33803923-C5E3162C-AECE-4521-B4EE-ADA2078E92FD Q33826323-BB4185BB-BD85-4A87-8FC8-AEF0CF4BA5A1 Q34385867-844E23CA-735F-492B-91EF-F1AAC2ABF5A1 Q34484260-52A7FD5C-5BC4-4F6D-AECC-3BC6642655FC Q34537885-D6116FD0-18CD-4B50-AE05-9A9432EB05CB Q34547888-BE632172-B06B-4144-91D8-C52FC9BAFD2A Q34871953-FB064CEC-02A8-4DBB-93E1-7CFA060A7CE1 Q35131201-9E4723F2-3399-47CC-BD29-1FD6E46B920E Q35196594-8E2B5CDD-C0C2-4F72-A724-42EB41DCC138 Q35343764-81881F0B-CEA6-4AB5-BB94-472041DEF1A4 Q35522087-711D70EB-8B8F-4C1F-9F88-F3F5290D02B6 Q35677885-EE1E0E1F-5458-4705-9EFB-F291ED0CA8F8 Q35678051-9E0E29C0-0E05-45DB-9A18-7B53B6950BC5 Q35835237-89C33D2E-389A-4394-AC66-929E57910FD7 Q35963911-D228B3FE-FFB5-47F5-A32D-35F582ECF30C Q36042474-28D23FE6-D362-4D7E-99A3-259A3AA2F661 Q36245668-5D783A16-0CEB-4C02-B2AE-4250901C7F66 Q36309539-2ED4EE88-FDFC-4EF5-B9AB-7A2A19F8A0DE Q36369834-28941563-1192-4961-924A-86439732E7F4 Q36400081-D01AF214-67F9-4BCB-BA45-2A005A5A321E Q36464545-8B5625E4-15FE-418E-A9C1-9761B461BF4A Q36524769-0DC4C132-A699-4A2F-9279-D2D12B95A061 Q36563027-DD099A4F-0F82-4D29-9BFA-34D19E1D8D0F Q37016687-33A41C41-86A7-4143-99AF-2FACB22E8442 Q37109728-98474B07-CC3F-4976-BAF4-8594FA9D2C30 Q37520294-1E637F85-E5B4-485B-8847-A0D1A1DE0FCA Q37580069-086A3613-2AB5-42E5-94BF-FC04B5C541EA Q37720601-E7F9298B-E3F3-4BEA-926B-52E0FA634100 Q38115619-4A0F376D-062F-4B28-9148-07993C0328C7

P2860

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.

http://www.wikidata.org/entity/Q38021384

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.

@en

type

label

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.

@en

prefLabel

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.

@en

P1433

Q38021384-3DFBB430-900E-492C-A863-262DF42DB185

P1476

Q38021384-88EF0625-7A3B-40A9-A4C0-174426DBBC85

P2093

Q38021384-B8A5714C-36E6-4EE0-9D0A-DA5A080D15EE

Q38021384-C2395088-EBCE-4607-AB50-A5B38E8CEA66

Q38021384-CC4EB1B7-B9F9-417F-9CF7-ED1DF0A8BC9F

P2860

Q38021384-000130C1-2429-4D96-B1FD-5FFAF8933CD3

Q38021384-05FFF025-EC69-4B79-A82D-01C52F66C5A5

Q38021384-07E94F6C-AF06-4055-9199-660469294935

Q38021384-0A6A10D8-D742-4F63-9DEB-7229F5FF2F58

Q38021384-0D62AF55-BB35-4045-A02B-4AD07EC281FF

Q38021384-0DEA0972-2AD2-4B29-A6BE-66CCD33446B5

Q38021384-0FE08134-AEF4-4324-85B5-1115239AC493

Q38021384-118AE6A6-521F-44C3-B042-53BDB2A5693F

Q38021384-126338FF-6BEA-4427-B05D-291FF7BF03B3

Q38021384-14101FE6-6B23-4D41-BC07-8B672328F682

P304

Q38021384-E7295A6E-E134-4B38-82C1-EAC83379931F

P31

Q38021384-CDD73269-39EC-4AAE-8EE7-8ECE38EB7E9E

P356

Q38021384-B2163EC4-5F31-4A6E-A926-F0AD0AC41A13

P433

Q38021384-7E7AB934-DBE4-4357-80D2-6C892E3BEDBC

P478

Q38021384-E31CFE27-EDC0-43DC-B33C-6E97032BCD9A

P577

Q38021384-B7C19761-79F6-4C08-801D-A3033383B24D

P698

Q38021384-5C6CC018-895E-4AB8-AF0E-6244A24396CF

P921

Q38021384-26185d8e-7764-4786-8a84-6d4e00c43974

Q38021384-FBB242E3-428B-4A89-B12E-9DBEE5F378A8

P356

P1433

Journal of Surgical Oncology

P1476

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.

@en

P2093

Charles J Yeo

http://www.w3.org/2001/XMLSchema#string

Jonathan R Brody

http://www.w3.org/2001/XMLSchema#string

Jordan M Winter

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

P304

15-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.23192

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22729569

http://www.w3.org/2001/XMLSchema#string

P921